Literature DB >> 9588881

Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells.

E Brabencova1, A Tazi, M Lorenzato, M Bonay, M Kambouchner, J F Emile, A J Hance, P Soler.   

Abstract

Pulmonary Langerhans cell granulomatosis (LCG), also called histiocytosis X, is a disorder of unknown etiology characterized by the presence of destructive granulomas containing numerous Langerhans cells (LCs). The process may be localized or multifocal, and it remains unclear whether the same pathogenic mechanism is involved in all forms of the disease. It is often assumed that the massive accumulation of LCs at the sites of the lesions results from the abnormal proliferation of these cells, although it has been suggested that LCG in adults, at least in the lung, could be a reactive disorder initiated by activated LCs. Little is known, however, concerning the mechanisms responsible for the accumulation of large numbers of LCs in the course of the disease, and the relative contribution of recruitment and local proliferation of these cells remains to be established. To investigate this question, the proportion of replicating LCs was evaluated in biopsied granulomas from patients with localized or diffuse form of LCG by means of several histopathological techniques currently used in assessment of cell proliferation. The findings demonstrate that, except for proliferating cell nuclear antigen (PCNA), all parameters measured are low in all forms of the disease. They are similar to those of renewing epithelial cells and clearly less than those of neoplastic cells. These data strongly suggest that LCs in LCG granulomas are not a rapidly dividing cell population and that local LC replication makes only a minimal contribution to granuloma maintenance. Caution appears to be necessary in the use of PCNA as a marker of growth fraction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588881      PMCID: PMC1858573     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

2.  Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle-associated antigen (Ki-67) in mycosis fungoides.

Authors:  B J Nickoloff; C E Griffiths
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

3.  Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.

Authors:  C Hage; C L Willman; B E Favara; P G Isaacson
Journal:  Hum Pathol       Date:  1993-08       Impact factor: 3.466

4.  The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate.

Authors:  D Trerè; A Pession; M Derenzini
Journal:  Exp Cell Res       Date:  1989-09       Impact factor: 3.905

5.  In situ identification of cycling Langerhans cells in normal human skin.

Authors:  D Parent; S Godfrine; C Dezutter-Dambuyant; M J Staquet; M Heenen; D Schmitt; J Thivolet
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

6.  Epidermal Langerhans cells--a cycling cell population.

Authors:  J Czernielewski; P Vaigot; M Prunièras
Journal:  J Invest Dermatol       Date:  1985-05       Impact factor: 8.551

7.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

Authors:  P A Hall; D A Levison; A L Woods; C C Yu; D B Kellock; J A Watkins; D M Barnes; C E Gillett; R Camplejohn; R Dover
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

8.  Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps; W Timens
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

9.  Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis.

Authors:  R C Yu; C Chu; L Buluwela; A C Chu
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

10.  Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

Authors:  C L Willman; L Busque; B B Griffith; B E Favara; K L McClain; M H Duncan; D G Gilliland
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

View more
  7 in total

Review 1.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 2.  Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2010 May-Jun       Impact factor: 2.409

3.  [Mandibular Langerhans cell histiocytosis: a case report].

Authors:  Jia-Shun Wu; Wei-Long Zhang; Zhu-Feng Li; Hao-Fan Wang; Xiao Yang; Mei Zhang; Ming-Zhong Yang; Yu Chen; Ya-Ling Tang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-04-01

4.  Multidetector CT findings of calvarial eosinophilic granuloma.

Authors:  Mehmet Fatih Inci; Rahime Inci; Fuat Ozkan
Journal:  BMJ Case Rep       Date:  2013-05-22

5.  MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.

Authors:  Huan Liu; Andrew R Osterburg; Jennifer Flury; Zulma Swank; Dennis W McGraw; Nishant Gupta; Kathryn A Wikenheiser-Brokamp; Ashish Kumar; Abdellatif Tazi; Yoshikazu Inoue; Masaki Hirose; Francis X McCormack; Michael T Borchers
Journal:  JCI Insight       Date:  2020-02-27

6.  KRASG12D expression in lung-resident myeloid cells promotes pulmonary LCH-like neoplasm sensitive to statin treatment.

Authors:  Tamihiro Kamata; Susan Giblett; Catrin Pritchard
Journal:  Blood       Date:  2017-05-26       Impact factor: 22.113

7.  Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.

Authors:  Brigitte Senechal; Gaelle Elain; Eric Jeziorski; Virginie Grondin; Natacha Patey-Mariaud de Serre; Francis Jaubert; Kheira Beldjord; Arielle Lellouch; Christophe Glorion; Michel Zerah; Pierre Mary; Mohammed Barkaoui; Jean Francois Emile; Liliane Boccon-Gibod; Patrice Josset; Marianne Debré; Alain Fischer; Jean Donadieu; Frederic Geissmann
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.